We are live on ! Find out more
ACA

Apis Capital Advisors Portfolio holdings

AUM $648M
1-Year Est. Return 302.67%
This Fund
S&P 500
This Quarter Est. Return
+32.84%
1 Year Est. Return
+302.67%
3 Year Est. Return
+1,035.2%
5 Year Est. Return
+2,376.05%
10 Year Est. Return
AUM
$82.9M
AUM Growth
+$8.31M
Cap. Flow
-$9.13M
Cap. Flow %
-11.01%
Top 10 Hldgs %
75.35%
Holding
34
New
8
Increased
4
Reduced
18
Closed
3

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$3.33M
2
NVCR icon
NovoCure
NVCR
+$2.68M
3
I
INTELSAT S. A.
I
+$2.12M
4
SIMO icon
Silicon Motion
SIMO
+$2.03M
5
GLNG icon
Golar LNG
GLNG
+$1.54M

Sector Composition

Rank Sector Weight
1 Healthcare 58.13%
2 Technology 9.62%
3 Consumer Discretionary 6.96%
4 Energy 6.21%
5 Industrials 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBRX icon
26
Forte Biosciences
FBRX
$1.57B
$537K 0.65%
132
-1
-0.8% -$3.86K
APYX icon
27
Apyx Medical
APYX
$173M
$442K 0.53%
70,000
-30,000
-30% -$232K
AXTI icon
28
AXT Inc
AXTI
$3.95B
$312K 0.38%
+70,000
New +$299K
TBCH
29
Turtle Beach Corp
TBCH
$243M
$227K 0.27%
+20,000
New +$301K
FRAN
30
DELISTED
Francesca's Holdings Corporation
FRAN
$119K 0.14%
+14,583
New +$142K
FCSC
31
DELISTED
Fibrocell Science Inc.
FCSC
$48K 0.06%
+25,000
New +$49.8K
AMRN
32
CALL
Amarin Corp
AMRN
$299M
-500
Closed -$136K
CASM
33
DELISTED
CAS Medical Systems, Inc.
CASM
-110,000
Closed -$176K
ESIO
34
DELISTED
Electro Scientific Industries
ESIO
-30,000
Closed -$899K

Similar funds

Apis Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Apis Capital Advisors held 34 positions worth $82.9M, up 11% from $74.6M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Apis Capital Advisors withdrew a net $9.13M in Q1 2019, closing 3 positions and reducing 18 holdings. Its most notable exit was Electro Scientific Industries, an estimated $899K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Apis Capital Advisors opened a new position in Aerie Pharmaceuticals worth $1.43M.

  • Apis Capital Advisors's largest Q1 2019 buy was Aerie Pharmaceuticals: 30,000 shares worth $1.43M.
  • Apis Capital Advisors added most to KEMET Corporation in Q1 2019, an estimated $2.39M increase.
  • Apis Capital Advisors's biggest Q1 2019 reduction was Array Biopharma Inc, cutting an estimated $3.33M.
  • Apis Capital Advisors fully exited Electro Scientific Industries in Q1 2019, selling an estimated $899K.
  • Apis Capital Advisors's ten largest holdings make up 75% of its $82.9M portfolio in Q1 2019.
  • Apis Capital Advisors opened 8 new positions and closed 3 in Q1 2019.
  • Apis Capital Advisors's portfolio value rose 11% quarter-over-quarter to $82.9M.

Based on Apis Capital Advisors's 13F filing for Q1 2019, filed 7 May 2019.